Grant Funding
A novel and rapid system to classify BRCA2 missense and other variants in ovarian cancer.
W81XWH1810269
Principal Investigator: Paul Andreassen
CDMRP (DoD), Ovarian Cancer Research Program
Through June 14, 2022
Functional characterization of the role of distinct domains of ATM and the impact of sequence variants on the DNA damage response.
R01 GM134731
Principal Investigator: Paul Andreassen
NIH
Through May 31, 2023
Reducing error-prone repair for therapeutic correction of sickle cell anemia.
Sickle Cell Disease/Advancing Cures Program
Principal Investigator: Punam Malik
Doris Duke Charitable Foundation
Through August 31, 2022
